NTAP
60
2
SYF
83
7
TRV
42
5
TEL
60
2
IBM
54
3
DGX
29
2
INTC
40
3
MRK
27
2
UAL
76
3
RF
44
3
YUM
43
3
GOOG
83
4
GRMN
59
6
ACN
54
4
MNST
52
6
A
47
4
RHI
50
2
PGR
53
5
NDAQ
50
4
MAC
54
3
NTAP
60
2
SYF
83
7
TRV
42
5
TEL
60
2
IBM
54
3
DGX
29
2
INTC
40
3
MRK
27
2
UAL
76
3
RF
44
3
YUM
43
3
GOOG
83
4
GRMN
59
6
ACN
54
4
MNST
52
6
A
47
4
RHI
50
2
PGR
53
5
NDAQ
50
4
MAC
54
3
Financhill
Back

Apollo Global Management Vs. Aligos Therapeutics Industry Stock Comparison

Buy
61

APO
Apollo Global Management

Last Price:
$173.92
Seasonality Move:
3.29%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$39.40
Seasonality Move:
7.18%
Buy
61
Apollo Global Management (APO) is a Buy

Is Apollo Global Management a Buy, Sell or Hold?

  • The current Apollo Global Management [APO] share price is $174.85. The Score for APO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • APO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $39.34. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APO Stock Price Chart

What is Apollo Global Management's stock price today?

  • The Apollo Global Management share price today is $174.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $39.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.88 Buy
Relative Strength Index (14 RSI): 57.38 Buy
Chaikin Money Flow: 1022518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (168.9 - 177.04) Buy
Bollinger Bands (100): (113.44 - 165.06) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.44 Buy
Relative Strength Index (14 RSI): 77.53 Buy
Chaikin Money Flow: -217768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.98 - 35.56) Buy
Bollinger Bands (100): (6.92 - 24.5) Buy

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 173.19 Buy
20-day SMA: 174.29 Buy
50-day SMA: 161.98 Buy
200-day SMA: 127.08 Buy
8-day EMA: 173.01 Buy
20-day EMA: 171.89 Buy
50-day EMA: 161.72 Buy
200-day EMA: 131.7 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.44 Buy
20-day SMA: 31.12 Buy
50-day SMA: 19.88 Buy
200-day SMA: 16.4 Buy
8-day EMA: 36.62 Buy
20-day EMA: 31.53 Buy
50-day EMA: 23.66 Buy
200-day EMA: 17.85 Buy

Apollo Global Management Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $1.42 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Apollo Global Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):